Stempoint-Capital-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
57
Total Value
295860128
Accession Number
0001420506-25-001189
Form Type
13F-HR
Manager Name
Stempoint-Capital-Lp
Data Enrichment
93% identified
53 identified4 unidentified

Holdings

57 positions • $295.9M total value
Manager:
Search and click to pin securities to the top
Page 3 of 3
Dyne Therapeutics, Inc.
Shares:84.4K
Value:$883.1K
% of Portfolio:0.3% ($883.1K/$295.9M)
SOLENO THERAPEUTICS INC
Shares:11.2K
Value:$797.0K
% of Portfolio:0.3% ($797.0K/$295.9M)
InflaRx N.V.
Shares:725.0K
Value:$739.5K
% of Portfolio:0.2% ($739.5K/$295.9M)
Solid Biosciences Inc.
Shares:198.2K
Value:$733.2K
% of Portfolio:0.2% ($733.2K/$295.9M)
Wave Life Sciences Ltd.
Shares:89.8K
Value:$725.9K
% of Portfolio:0.2% ($725.9K/$295.9M)
MBX Biosciences, Inc.
Shares:96.6K
Value:$713.0K
% of Portfolio:0.2% ($713.0K/$295.9M)
829401108
Shares:60.0K
Value:$627.6K
% of Portfolio:0.2% ($627.6K/$295.9M)
Bicara Therapeutics Inc.
Shares:47.1K
Value:$613.4K
% of Portfolio:0.2% ($613.4K/$295.9M)
Edgewise Therapeutics, Inc.
Shares:50.0K
Value:$237.5K
% of Portfolio:0.1% ($237.5K/$295.9M)
CVS HEALTH Corp
Shares:64.1K
Value:$165.1K
% of Portfolio:0.1% ($165.1K/$295.9M)
Mineralys Therapeutics, Inc.
Shares:125.0K
Value:$93.8K
% of Portfolio:0.0% ($93.8K/$295.9M)
Arcutis Biotherapeutics, Inc.
Shares:100.0K
Value:$42.5K
% of Portfolio:0.0% ($42.5K/$295.9M)
KalVista Pharmaceuticals, Inc.
Shares:100.0K
Value:$32.5K
% of Portfolio:0.0% ($32.5K/$295.9M)
26923G301
Shares:132.5K
Value:$16.6K
% of Portfolio:0.0% ($16.6K/$295.9M)
RHYTHM PHARMACEUTICALS, INC.
Shares:10.0K
Value:$15.5K
% of Portfolio:0.0% ($15.5K/$295.9M)
Merck & Co., Inc.
Shares:151.7K
Value:$8.3K
% of Portfolio:0.0% ($8.3K/$295.9M)
NOVO NORDISK A S
Shares:151.7K
Value:$3.8K
% of Portfolio:0.0% ($3.8K/$295.9M)